Expertise in
2
conditions

Dr. Chad E. Miller

Family Medicine
Kaiser Permanente Skyline Pharmacy
1375 E 20th Ave, 
Denver, CO 
Expertise in
2
conditions
Kaiser Permanente Skyline Pharmacy
1375 E 20th Ave, 
Denver, CO 

Overview

Chad Miller is a primary care provider, practicing in Family Medicine in Denver, Colorado.

Dr. Miller is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension and Hypertension.

He is actively involved in clinical research, co-authoring 13 peer reviewed articles and participating in 9 clinical trials.

Specialties

Family Medicine

Licenses

General Practice in CO

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Kaiser Permanente Skyline Pharmacy
1375 E 20th Ave, Denver, CO 80205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: June 16, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

13 Total Publications

Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review.
Transitioning Prostacyclin Pathway Agents to Oral Selexipag in Patients with Pulmonary Arterial Hypertension: A Systematic Literature Review.
Journal: Advances in therapy
Published: October 29, 2025
Similar Doctors
Expertise in
59
conditions
Dr. Danielle A. Whitacre
Family Medicine
Expertise in
59
conditions
Dr. Danielle A. Whitacre
Family Medicine

Bloom Healthcare

10900 W 44th Ave Unit 200, 
Wheat Ridge, CO 
 (8.2 miles away)
303-284-4082
Languages Spoken:
English
See accepted insurances

Danielle Whitacre is a primary care provider, practicing in Family Medicine in Wheat Ridge, Colorado. Dr. Whitacre is highly rated in 59 conditions, according to our data. Her clinical expertise encompasses Mucopolysaccharidosis Type 3 (MPS III, Sanfilippo Syndrome), Mucopolysaccharidosis Type 3A (MPS IIIA, Sanfilippo Syndrome A), Mucopolysaccharidosis Type 3B (MPS IIIB, Sanfilippo Syndrome B), and Apparent Mineralocorticoid Excess.

Expertise in
4
conditions
Dr. Joerg H. Skomrock
Family Medicine
Expertise in
4
conditions
Dr. Joerg H. Skomrock
Family Medicine

Denver Wound Healing Center

1719 E 19th Ave, 
Denver, CO 
 (0.2 miles away)
Languages Spoken:
English
See accepted insurances

Joerg Skomrock is a primary care provider, practicing in Family Medicine in Denver, Colorado. Dr. Skomrock is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Peptic Ulcer, Necrosis, Cellulitis, and Stasis Dermatitis and Ulcers.

Expertise in
63
conditions
Dr. John R. Willard
Family Medicine
Expertise in
63
conditions
Dr. John R. Willard
Family Medicine

Dr. Willard's Family Practice, PC

14100 E Arapahoe Rd, Ste 170, 
Centennial, CO 
 (13.1 miles away)
303-699-3190
Languages Spoken:
English
See accepted insurances
Accepting New Patients

John Willard is a primary care provider, practicing in Family Medicine in Centennial, Colorado. Dr. Willard is highly rated in 63 conditions, according to our data. His clinical expertise encompasses Hypertensive Heart Disease, Enlarged Liver, Pediatric Myocarditis, and High Cholesterol. Dr. Willard is currently accepting new patients.

Frequently Asked Questions about Dr. Chad E. Miller

How do I make an appointment with Dr. Chad E. Miller?

You can book an appointment with Dr. Chad E. Miller by calling their office at 303-764-4507. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Chad E. Miller a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Chad E. Miller is classified as an Advanced expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Chad E. Miller specialize in?

While Dr. Chad E. Miller is a Family Medicine, they have specific expertise in Pulmonary Hypertension, Hypertension. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Chad E. Miller participate in research or clinical trials?

Yes. Dr. Chad E. Miller has published 13 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Chad E. Miller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miller's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile